Literature DB >> 16179355

Kinetic mechanism of myosin IXB and the contributions of two class IX-specific regions.

Vijayalaxmi Nalavadi1, Miklós Nyitrai, Cristina Bertolini, Nancy Adamek, Michael A Geeves, Martin Bähler.   

Abstract

Myosin IXb (Myo9b) was reported to be a single-headed, processive myosin. In its head domain it contains an N-terminal extension and a large loop 2 insertion that are specific for class IX myosins. We characterized the kinetic properties of purified, recombinant rat Myo9b, and we compared them with those of Myo9b mutants that had either the N-terminal extension or the loop 2 insertion deleted. Unlike other processive myosins, Myo9b exhibited a low affinity for ADP, and ADP release was not rate-limiting in the ATPase cycle. Myo9b is the first myosin for which ATP hydrolysis or an isomerization step after ATP binding is rate-limiting. Myo9b-ATP appeared to be in a conformation with a weak affinity for actin as determined by pyrene-actin fluorescence. However, in actin cosedimentation experiments, a subpopulation of Myo9b-ATP bound F-actin with a remarkably high affinity. Deletion of the N-terminal extension reduced actin affinity and increased the rate of nucleotide binding. Deletion of the loop 2 insertion reduced the actin affinity and altered the communication between actin and nucleotide-binding sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179355     DOI: 10.1074/jbc.M507161200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Head of myosin IX binds calmodulin and moves processively toward the plus-end of actin filaments.

Authors:  Wanqin Liao; Kerstin Elfrink; Martin Bähler
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis.

Authors:  Troy C Krzysiak; Susan P Gilbert
Journal:  J Biol Chem       Date:  2006-10-23       Impact factor: 5.157

3.  Loop 2 of limulus myosin III is phosphorylated by protein kinase A and autophosphorylation.

Authors:  Karen Kempler; Judit Tóth; Roxanne Yamashita; Gretchen Mapel; Kimberly Robinson; Helene Cardasis; Stanley Stevens; James R Sellers; Barbara-Anne Battelle
Journal:  Biochemistry       Date:  2007-03-17       Impact factor: 3.162

4.  Functional characterization of human myosin-18A and its interaction with F-actin and GOLPH3.

Authors:  Manuel H Taft; Elmar Behrmann; Lena-Christin Munske-Weidemann; Claudia Thiel; Stefan Raunser; Dietmar J Manstein
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

5.  Kinetic signatures of myosin-5B, the motor involved in microvillus inclusion disease.

Authors:  Sarah M Heissler; Krishna Chinthalapudi; James R Sellers
Journal:  J Biol Chem       Date:  2017-09-07       Impact factor: 5.157

6.  The Myosin IXb motor activity targets the myosin IXb RhoGAP domain as cargo to sites of actin polymerization.

Authors:  Frank van den Boom; Heiko Düssmann; Katharina Uhlenbrock; Marouan Abouhamed; Martin Bähler
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

7.  A nonprocessive class V myosin drives cargo processively when a kinesin- related protein is a passenger.

Authors:  Alex R Hodges; Carol S Bookwalter; Elena B Krementsova; Kathleen M Trybus
Journal:  Curr Biol       Date:  2009-12-10       Impact factor: 10.834

8.  Noncanonical Myo9b-RhoGAP Accelerates RhoA GTP Hydrolysis by a Dual-Arginine-Finger Mechanism.

Authors:  Fengshuang Yi; Ruirui Kong; Jinqi Ren; Li Zhu; Jizhong Lou; Jane Y Wu; Wei Feng
Journal:  J Mol Biol       Date:  2016-06-27       Impact factor: 5.469

9.  Biochemical and bioinformatic analysis of the myosin-XIX motor domain.

Authors:  Rebecca C Adikes; William C Unrath; Christopher M Yengo; Omar A Quintero
Journal:  Cytoskeleton (Hoboken)       Date:  2013-05-02

10.  Self-organization of actin networks by a monomeric myosin.

Authors:  Dario Saczko-Brack; Ewa Warchol; Benoit Rogez; Markus Kröss; Sarah M Heissler; James R Sellers; Christopher Batters; Claudia Veigel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.